STOCK TITAN

LENSAR director sells 22,214 and 10,961 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

LENSAR, Inc. director Elizabeth G. O'Farrell exercised options for 22,214 shares at $3.23 and sold those shares on November 17, 2026, at a weighted average of $5.20 per share (sales ranged from $5.00 to $5.285). On November 18, 2026, she exercised options for 10,961 shares at $3.23 and sold those shares at a weighted average of $4.97 per share (sales ranged from $4.96 to $4.97). No Rule 10b5-1 plan is reported.

Insider O'Farrell Elizabeth G.
Role Director
Sold 33,175 shs ($170K)
Approx. gross sale proceeds $170K
Approx. exercise cost $107K
Approx. pre-tax spread $63K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3 10,961 $0.00 $0.00
Exercise Common Stock 10,961 $3.23 $35K
Sale Common Stock F2 10,961 $4.97 $54K
Exercise Stock Option (Right to Buy) F3 22,214 $0.00 $0.00
Exercise Common Stock 22,214 $3.23 $72K
Sale Common Stock F1 22,214 $5.20 $116K
Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Common Stock — 67,368 shares (Direct)
Footnotes (3)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.285. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $4.97. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The option vested in twelve (12) substantially equal monthly installments commencing June 25, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.
Options exercised 22,214 shares November 17, 2026
Exercise price $3.23 per share Options exercised November 17, 2026
Shares sold 22,214 shares November 17, 2026
Weighted average sale price $5.20 per share November 17, 2026; sales ranged from $5.00 to $5.285
Options exercised 10,961 shares November 18, 2026
Exercise price $3.23 per share Options exercised November 18, 2026
Shares sold 10,961 shares November 18, 2026
Weighted average sale price $4.97 per share November 18, 2026; sales ranged from $4.96 to $4.97
weighted average price financial
"the 22,214-share sale reported for November 17, 2026"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vesting financial
"the option vested in twelve substantially equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
non-employee director compensation program financial
"the option was granted under the director compensation program"
Rule 10b5-1 plan regulatory
"no Rule 10b5-1 plan is reported for the transactions"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LNSR shares did Elizabeth G. O'Farrell sell, and at what prices?

She sold 22,214 shares at a $5.20 weighted average price on November 17, 2026, with transactions ranging from $5.00 to $5.285. On November 18, 2026, she sold 10,961 shares at a $4.97 weighted average price, with transactions ranging from $4.96 to $4.97.

What were the terms of Elizabeth G. O'Farrell's LNSR options?

The options vested in 12 substantially equal monthly installments beginning June 25, 2023, subject to her continued service through each vesting date. They were granted under LENSAR's non-employee director compensation program as part of her annual compensation for service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
O'Farrell Elizabeth G.

(Last)(First)(Middle)
2800 DISCOVERY DRIVE

(Street)
ORLANDO FLORIDA 32826

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LENSAR, Inc. [ LNSR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/17/2026M22,214A$3.2389,582D
Common Stock11/17/2026S22,214D$5.2(1)67,368D
Common Stock11/18/2026M10,961A$3.2378,329D
Common Stock11/18/2026S10,961D$4.97(2)67,368D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.2311/17/2026M22,214 (3)05/25/2033Common Stock22,214$010,961D
Stock Option (Right to Buy)$3.2311/18/2026M10,961 (3)05/25/2033Common Stock10,961$00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.285. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $4.97. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The option vested in twelve (12) substantially equal monthly installments commencing June 25, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.
/s/ Nicholas T. Curtis, attorney-in-fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading